Sanil Joseph

Dr. Sanil Joseph

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2024 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SJSanil Joseph
Sanil Joseph
JSJerrome Selvaraj
Jerrome Selvaraj
IMIswarya Mani
Iswarya Mani
TKThandavarayan Kumaragurupari
Thandavarayan Kumaragurupari
XSXianwen Shang
Xianwen Shang
MHMingguang He
Mingguang He

10 January 2024 in eClinicalMedicine
Verified
Journal Article
Open access
WHWenyi Hu
Wenyi Hu
SJSanil Joseph
Sanil Joseph
RLRui Li
Rui Li
EWEkaterina Woods
Ekaterina Woods
JSJason Sun
Jason Sun
LZLei Zhang
Lei Zhang
We aimed to evaluate the cost-effectiveness of an artificial intelligence-(AI) based diabetic retinopathy (DR) screening system in the primary care setting for both non-Indigenous and Indigenous people living with diabetes in Australia. We performed a cost-effectiveness analysis between January 01, 2022 and August 01, 2023. A decision-analytic Markov model was constructed to simulate DR progression in a population of 1,197,818 non-Indigenous and 65,160 Indigenous Australians living with diabetes aged ≥20 years over 40 years. From a healthcare provider's perspective, we compared current practice to three primary care AI-based screening scenarios-(A) substitution of current manual grading, (B) scaling up to patient acceptance level, and (C) achieving universal screening. Study results were presented as incremental cost-effectiveness ratio (ICER), benefit-cost ratio (BCR), and net monetary benefits (NMB). A Willingness-to-pay (WTP) threshold of AU$50,000 per quality-adjusted life year (QALY) and a discount rate of 3.5% were adopted in this study. With the status quo, the non-Indigenous diabetic population was projected to develop 96,269 blindness cases, resulting in AU$13,039.6 m spending on DR screening and treatment during 2020-2060. In comparison, all three intervention scenarios were effective and cost-saving. In particular, if a universal screening program was to be implemented (Scenario C), it would prevent 38,347 blindness cases, gain 172,090 QALYs and save AU$595.8 m, leading to a BCR of 3.96 and NMB of AU$9,200 m. Similar findings were also reported in the Indigenous population. With the status quo, 3,396 Indigenous individuals would develop blindness, which would cost the health system AU$796.0 m during 2020-2060. All three intervention scenarios were cost-saving for the Indigenous population. Notably, universal AI-based DR screening (Scenario C) would prevent 1,211 blindness cases and gain 9,800 QALYs in the Indigenous population, leading to a saving of AU$19.2 m with a BCR of 1.62 and NMB of AU$509 m. Our findings suggest that implementing AI-based DR screening in primary care is highly effective and cost-saving in both Indigenous and non-Indigenous populations. This project received grant funding from the Australian Government: the National Critical Research Infrastructure Initiative, Medical Research Future Fund (MRFAI00035) and the NHMRC Investigator Grant (APP1175405). The contents of the published material are solely the responsibility of the Administering Institution, a participating institution or individual authors and do not reflect the views of the NHMRC. This work was supported by the Global STEM Professorship Scheme (P0046113), the Fundamental Research Funds of the State Key Laboratory of Ophthalmology, Project of Investigation on Health Status of Employees in Financial Industry in Guangzhou, China (Z012014075). The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian State Government. W.H. is supported by the Melbourne Research Scholarship established by the University of Melbourne. The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

1 July 2019 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
SJSanil Joseph
Sanil Joseph
RKRamasamy Kim
Ramasamy Kim
RRRavilla D. Ravindran
Ravilla D. Ravindran
AFAstrid E. Fletcher
Astrid E. Fletcher
Thulasiraj RavillaThulasiraj Ravilla
Thulasiraj Ravilla
It has been estimated that there are 65 million people with diabetes in India, and another 22 million in the high-risk prediabetes stage, with the total number of diabetes cases projected to increase to 109 million by 2035.1 These numbers suggest a great need to expand services for diabetes and develop appropriate prevention and control interventions.2 A visual consequence of diabetes is diabetic retinopathy (DR). Population-based surveys in India have reported DR in 10% to 30% of adults with diabetes, with higher rates found in older people and urban areas.3-10 Early identification of DR with appropriate treatment is necessary to reduce the rate of vision loss. Key recommendations from the World Health Organization include periodic eye examinations, strategies to increase awareness among people with diabetes and their physicians of the importance of eye examinations, and methods to address barriers to the uptake of the strategies.2 In India, ad hoc one-time screening by outreach camps in rural or urban areas has been undertaken11 but does not fulfill the requirement for periodic eye examinations. Even specialist diabetes clinics face barriers owing to lack of awareness of DR by patients and paramedical staff and low uptake of retinal specialist referral because of costs and limited access.12,13 In developing countries, including India, inadequate eye care resources, both in infrastructure and personnel, is a reality.14 Teleretinal screening for DR is increasingly being used in India.15,16 There is limited evidence from randomized clinical trials on the benefits of teleretinal screening from studies in high-income countries.17-21 The objective of the present study was to evaluate the effectiveness of teleretinal screening in the Indian setting.

25 March 2018 in Ophthalmic and Physiological Optics
Verified
Journal Article
Open access
PDF file
SJSanil Joseph
Sanil Joseph
TKTiruvengada Krishnan
Tiruvengada Krishnan
RRRavilla D. Ravindran
Ravilla D. Ravindran
GMGiovanni Maraini
Giovanni Maraini
MCMonica Camparini
Monica Camparini
AFAstrid E. Fletcher
Astrid E. Fletcher
Purpose: To investigate prevalence and risk factors for myopia, hyperopia and astigmatism in southern India. Methods: Randomly sampled villages were enumerated to identify people aged ≥40 years. Participants were interviewed for socioeconomic and lifestyle factors and attended a hospital‐based ophthalmic examination including visual acuity measurement and objective and subjective measurement of refractive status. Myopia was defined as spherical equivalent ( SE ) worse than −0.75 dioptres (D), hyperopia as SE ≥+1D and astigmatism as cylinder <−0.5. Results: The age‐standardised prevalences of myopia, hyperopia and astigmatism were 35.6% (95% CI : 34.7–36.6), 17.0% (95% CI : 16.3–17.8) and 32.6 (29.3–36.1), respectively. Of those with myopia ( n = 1490), 70% had advanced cataract. Of these, 79% had presenting visual acuity ( VA ) less than 6/18 and after best correction, 44% of these improved to 6/12 or better and 27% remained with VA less than 6/18. In multivariable analyses (excluding patients with advanced cataract), increasing nuclear opacity score, current tobacco use, and increasing height were associated with higher odds of myopia. Higher levels of education were associated with increased odds of myopia in younger people and decreased odds in older people. Increasing time outdoors was associated with myopia only in older people. Increasing age and female gender were associated with hyperopia, and nuclear opacity score, increasing time outdoors, rural residence and current tobacco use with lower odds of hyperopia. After controlling for myopia, factors associated with higher odds of astigmatism were age, rural residence, and increasing nuclear opacity score and increasing education with lower odds. Conclusions: In contrast to high‐income settings and in agreement with studies from low‐income settings, we found a rise in myopia with increasing age reflecting the high prevalence of advanced cataract.

14 June 2019 in BMJ Open Ophthalmology
Verified
Journal Article
Open access
PDF file
NDNicholas Durr
Nicholas Durr
SDShivang R Dave
Shivang R Dave
DLDaryl Lim
Daryl Lim
SJSanil Joseph
Sanil Joseph
Thulasiraj RavillaThulasiraj Ravilla
Thulasiraj Ravilla
ELEduardo Lage
Eduardo Lage
Objective To assess the quality of eyeglass prescriptions provided by an affordable wavefront autorefractor operated by a minimally trained technician in a low-resource setting. Methods and Analysis 708 participants were recruited from consecutive patients registered for routine eye examinations at Aravind Eye Hospital in Madurai, India, or an affiliated rural satellite vision centre. Visual acuity (VA) and patient preference were compared between trial lenses set to two eyeglass prescriptions from (1) a novel wavefront autorefractor and (2) subjective refraction by an experienced refractionist. Results The mean±SD VA was 0.30±0.37, –0.02±0.14 and −0.04±0.11 logarithm of the minimum angle of resolution units before correction, with autorefractor correction and with subjective refraction correction, respectively (all differences p<0.01). Overall, 25% of participants had no preference, 33% preferred eyeglass prescriptions from autorefraction, and 42% preferred eyeglass prescriptions from subjective refraction (p<0.01). Of the 438 patients 40 years old and younger, 96 had no preference and the remainder had no statistically significant difference in preference for subjective refraction prescriptions (51%) versus autorefractor prescriptions (49%) (p=0.52). Conclusion Average VAs from autorefractor-prescribed eyeglasses were one letter worse than those from subjective refraction. More than half of all participants either had no preference or preferred eyeglasses prescribed by the autorefractor. This marginal difference in quality may warrant autorefractor-based prescriptions, given the portable form factor, short measurement time, low cost and minimal training required to use the autorefractor evaluated here.

1 December 2021 in Ophthalmology
Verified
Journal Article
Open access
SJSanil Joseph
Sanil Joseph
VVVarshini Varadaraj
Varshini Varadaraj
SDShivang R. Dave
Shivang R. Dave
ENEduardo Lage Negro
Eduardo Lage Negro
DLDaryl Lim
Daryl Lim
DFDavid S. Friedman
David S. Friedman
To compare patient preferences for eyeglasses prescribed using a low-cost, portable wavefront autorefractor versus standard subjective refraction (SR). Randomized, cross-over clinical trial. Patients aged 18 to 40 years presenting with refractive errors (REs) to a tertiary eye hospital in Southern India. Participants underwent SR followed by autorefraction (AR) using the monocular version of the QuickSee device (PlenOptika Inc). An independent optician, masked to the refraction approach, prepared eyeglasses based on each refraction approach. Participants (masked to refraction source) were randomly assigned to use SR- or AR-based eyeglasses first, followed by the other pair, for 1 week each. At the end of each week, participants had their vision checked and were interviewed about their experience with the eyeglasses. Patients preferring eyeglasses were chosen using AR and SR. The 400 participants enrolled between March 26, 2018, and August 2, 2019, had a mean (standard deviation) age of 28.4 (6.6) years, and 68.8% were women. There was a strong correlation between spherical equivalents using SR and AR (r = 0.97, P < 0.001) with a mean difference of -0.07 diopters (D) (95% limits of agreement [LoA], -0.68 to 0.83). Of the 301 patients (75.2%) who completed both follow-up visits, 50.5% (n = 152) and 49.5% (n = 149) preferred glasses prescribed using SR and AR, respectively (95% CI, 45.7-56.3; P = 0.86). There were no differences in demographic or vision characteristics between participants with different preferences (P > 0.05 for all). We observed a strong agreement between the prescriptions from SR and AR, and eyeglasses prescribed using SR and AR were equally preferred by patients. Wider use of prescribing based on AR alone in resource-limited settings is supported by these findings.